Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4762329
Max Phase: Preclinical
Molecular Formula: C52H73N11O10S
Molecular Weight: 1044.29
Molecule Type: Unknown
Associated Items:
ID: ALA4762329
Max Phase: Preclinical
Molecular Formula: C52H73N11O10S
Molecular Weight: 1044.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(N)=O
Standard InChI: InChI=1S/C52H73N11O10S/c1-28(2)43(45(55)66)62-50(71)41(27-74)61-48(69)38(24-32-18-20-34(65)21-19-32)58-46(67)37(17-11-12-22-53)57-49(70)40(25-33-26-56-36-16-10-9-15-35(33)36)59-47(68)39(23-31-13-7-6-8-14-31)60-52(73)44(29(3)4)63-51(72)42(54)30(5)64/h6-10,13-16,18-21,26,28-30,37-44,56,64-65,74H,11-12,17,22-25,27,53-54H2,1-5H3,(H2,55,66)(H,57,70)(H,58,67)(H,59,68)(H,60,73)(H,61,69)(H,62,71)(H,63,72)/t30-,37+,38+,39+,40+,41+,42+,43+,44+/m1/s1
Standard InChI Key: XIUZNUDCFITGHW-PCMWHEESSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1044.29 | Molecular Weight (Monoisotopic): 1043.5263 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):